| scholarly article | Q13442814 |
| P50 | author | Myron M. Levine | Q29564379 |
| Stefanie N. Vogel | Q92126561 | ||
| Leah E Cole | Q123569288 | ||
| P2093 | author name string | Aiping Qin | |
| Barbara J Mann | |||
| Araceli E Santiago | |||
| Eileen M Barry | |||
| Christen Grassel | |||
| Aimee L Cunningham | |||
| P2860 | cites work | Live attenuated Francisella novicida vaccine protects against Francisella tularensis pulmonary challenge in rats and non-human primates | Q27323387 |
| Tularemia in BALB/c and C57BL/6 mice vaccinated with Francisella tularensis LVS and challenged intradermally, or by aerosol with virulent isolates of the pathogen: protection varies depending on pathogen virulence, route of exposure, and host geneti | Q73816633 | ||
| Tularemia vaccine study. II. Respiratory challenge | Q79015704 | ||
| Identification of Francisella tularensis lipoproteins that stimulate the toll-like receptor (TLR) 2/TLR1 heterodimer | Q80197122 | ||
| Safety and immunogenicity of CVD 1208S, a live, oral DeltaguaBA Deltasen Deltaset Shigella flexneri 2a vaccine grown on animal-free media | Q81445405 | ||
| Live attenuated mutants of Francisella tularensis protect rabbits against aerosol challenge with a virulent type A strain | Q30409782 | ||
| Requirement of the CXXC motif of novel Francisella infectivity potentiator protein B FipB, and FipA in virulence of F. tularensis subsp. tularensis | Q30430676 | ||
| Identification of an essential Francisella tularensis subsp. tularensis virulence factor | Q30439303 | ||
| Francisella tularensis subsp. tularensis Schu S4 disulfide bond formation protein B, but not an RND-type efflux pump, is required for virulence | Q30440960 | ||
| A Francisella tularensis Schu S4 purine auxotroph is highly attenuated in mice but offers limited protection against homologous intranasal challenge | Q33346284 | ||
| Shigella flexneri 2a strain CVD 1207, with specific deletions in virG, sen, set, and guaBA, is highly attenuated in humans | Q34003433 | ||
| Induction of protective immunity against Chlamydia muridarum intravaginal infection with the chlamydial immunodominant antigen macrophage infectivity potentiator | Q34445366 | ||
| Mucosal immunization with live attenuated Francisella novicida U112ΔiglB protects against pulmonary F. tularensis SCHU S4 in the Fischer 344 rat model | Q34464553 | ||
| Construction and characterization of an attenuated purine auxotroph in a Francisella tularensis live vaccine strain | Q34975711 | ||
| Attenuated Francisella novicida transposon mutants protect mice against wild-type challenge | Q35073798 | ||
| The Neisseria meningitidis macrophage infectivity potentiator protein induces cross-strain serum bactericidal activity and is a potential serogroup B vaccine candidate | Q35191903 | ||
| A Burkholderia pseudomallei macrophage infectivity potentiator-like protein has rapamycin-inhibitable peptidylprolyl isomerase activity and pleiotropic effects on virulence | Q35671633 | ||
| In vivo negative selection screen identifies genes required for Francisella virulence | Q35699734 | ||
| Molecular characterization and subcellular localization of macrophage infectivity potentiator, a Chlamydia trachomatis lipoprotein | Q35879416 | ||
| Type I interferon signaling is required for activation of the inflammasome during Francisella infection | Q36229342 | ||
| A 28 kDa major immunogen of Chlamydia psittaci shares identity with Mip proteins of Legionella spp. and Chlamydia trachomatis-cloning and characterization of the C. psittaci mip-like gene | Q36834560 | ||
| Activation of the inflammasome upon Francisella tularensis infection: interplay of innate immune pathways and virulence factors. | Q36896004 | ||
| Nucleotide sequence analysis of the Legionella micdadei mip gene, encoding a 30-kilodalton analog of the Legionella pneumophila Mip protein | Q36988488 | ||
| Structure and mechanisms of the DsbB-DsbA disulfide bond generation machine. | Q37033153 | ||
| Legionella pneumophila mip gene potentiates intracellular infection of protozoa and human macrophages | Q37048382 | ||
| The inflammasome: a key player in the inflammation triggered in response to bacterial pathogens | Q37114492 | ||
| The disulfide bond formation (Dsb) system | Q37136271 | ||
| Characterization of rationally attenuated Francisella tularensis vaccine strains that harbor deletions in the guaA and guaB genes | Q37276296 | ||
| Vaccination with a defined Francisella tularensis subsp. novicida pathogenicity island mutant (DeltaiglB) induces protective immunity against homotypic and heterotypic challenge | Q37364640 | ||
| DSB proteins and bacterial pathogenicity. | Q37386934 | ||
| Disulfide bond formation system in Escherichia coli. | Q37536471 | ||
| The proinflammatory cytokine response to Chlamydia trachomatis elementary bodies in human macrophages is partly mediated by a lipoprotein, the macrophage infectivity potentiator, through TLR2/TLR1/TLR6 and CD14. | Q37858322 | ||
| Molecular cloning of a Coxiella burnetii gene encoding a macrophage infectivity potentiator (Mip) analogue | Q37886288 | ||
| Chlamydia trachomatis contains a protein similar to the Legionella pneumophila mip gene product | Q37895508 | ||
| Protein disulfide bond generation in Escherichia coli DsbB-DsbA. | Q38606615 | ||
| Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines | Q39513114 | ||
| Intracellular multiplication and virulence of Shigella flexneri auxotrophic mutants. | Q39569905 | ||
| Antibodies are generated during infection to Coxiella burnetii macrophage infectivity potentiator protein (Cb-Mip). | Q40658460 | ||
| Aerogenic immunization of man with live Tularemia vaccine | Q40720507 | ||
| Construction of genetically defined double aro mutants of Salmonella typhi | Q40743402 | ||
| The use of live attenuated Salmonella for oral vaccination | Q43418467 | ||
| Molecular analysis of two novel Neisseria gonorrhoeae virulent components: the macrophage infectivity potentiator and the outer membrane protein A. | Q43769755 | ||
| Collagen binding protein Mip enables Legionella pneumophila to transmigrate through a barrier of NCI-H292 lung epithelial cells and extracellular matrix | Q46300643 | ||
| P433 | issue | 6 | |
| P921 | main subject | Francisella tularensis | Q1003460 |
| attenuated vaccine | Q1810913 | ||
| P304 | page(s) | ftv036 | |
| P577 | publication date | 2015-05-17 | |
| P1433 | published in | Pathogens and disease | Q27724629 |
| P1476 | title | Characterization of Francisella tularensis Schu S4 defined mutants as live-attenuated vaccine candidates | |
| P478 | volume | 73 |
| Q57805360 | Aerosol prime-boost vaccination provides strong protection in outbred rabbits against virulent type A Francisella tularensis |
| Q37438123 | An In Vitro Co-culture Mouse Model Demonstrates Efficient Vaccine-Mediated Control of Francisella tularensis SCHU S4 and Identifies Nitric Oxide as a Predictor of Efficacy |
| Q40121791 | Benzoxazoles, phthalazinones, and arylurea-based compounds with IMPDH-independent antibacterial activity against Francisella tularensis. |
| Q50133614 | Deletion of the Major Facilitator Superfamily Transporter fptB Alters Host Cell Interactions and Attenuates Virulence of Type A Francisella tularensis |
| Q55070411 | Live Attenuated Tularemia Vaccines for Protection Against Respiratory Challenge With Virulent F. tularensis subsp. tularensis. |
| Q35875539 | Phylogenetic analysis of human Chlamydia pneumoniae strains reveals a distinct Australian indigenous clade that predates European exploration of the continent. |
| Q40093204 | Respiratory and oral vaccination improves protection conferred by the live vaccine strain against pneumonic tularemia in the rabbit model |
| Q38838074 | Tularemia vaccines. |
Search more.